Mohammad Safaie Yazdi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Mohammad Safaie Yazdi has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
Charles H. Rundle
Musculoskeletal Disease Center, Jerry L. Pettis Memorial VA Medical Center, Loma Linda, California, USA
1 shared publicationDavid J. Baylink
Division of Regenerative Medicine, Department of Medicine, Loma Linda University, Loma Linda, California, USA
1 shared publication- Edmundo E. Carreon
Division of Regenerative Medicine, Department of Medicine, Loma Linda University, Loma Linda, California, USA
1 shared publication - Kin-Hing William Lau
VA Loma Linda Healthcare System, Jerry L. Pettis Memorial VA Medical Center, Loma Linda, CA 92357, USA
1 shared publication - Samiksha Wasnik
Division of Regenerative Medicine, Department of Medicine, Loma Linda University, Loma Linda, CA 92354, USA
1 shared publication - Xiaolei Tang
Department of Veterinary Biomedical Sciences, College of Veterinary Medicine, Long Island University, Brookville, NY 11548, USA
1 shared publication
Latest Publications
- Open Access
- 6 September 2018
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 3 (17)
1,25-Dihydroxyvitamin D suppresses M1 macrophages and promotes M2 differentiation at bone injury sites
An indispensable role of macrophages in bone repair has been well recognized. Previous data have demonstrated the copresence of M1 macrophages and mesenchymal stem cells (MSCs) during the proinflammatory stage of bone repair. However, the exact role of M1 macrophages in MSC function and bone repair is unknown. This study aimed to define the role of M1 macrophages at bone injury sites via the function of 1,25-Dihydroxyvitamin D (1,25[OH] 2 D) in suppressing M1 but promoting M2 differentiation. We showed that 1,25(OH) 2 D suppressed M1 macrophage–mediated enhancement of MSC migration. Additionally, 1,25(OH) 2 D inhibited M1 macrophage secretion of osteogenic proteins (i.e., Oncostatin M, TNF-α, and IL-6). Importantly, the 1,25(OH) 2 D-mediated suppression of osteogenic function in M1 macrophages at the proinflammatory stage was associated with 1,25(OH) 2 D-mediated reduction of MSC abundance, compromised osteogenic potential of MSCs, and impairment of fracture repair. Furthermore, outside the proinflammatory stage, 1,25(OH) 2 D treatment did not suppress fracture repair. Accordingly, our data support 2 conclusions: (a) M1 macrophages are important for the recruitment and osteogenic priming of MSCs and, hence, are necessary for fracture repair, and (b) under vitamin D–sufficient conditions, 1,25(OH) 2 D treatment is unnecessary and can be detrimental if provided during the proinflammatory stage of fracture healing.
- 6 September 2018
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 3 (17)
Open Access1,25-Dihydroxyvitamin D suppresses M1 macrophages and promotes M2 differentiation at bone injury sites
An indispensable role of macrophages in bone repair has been well recognized. Previous data have demonstrated the copresence of M1 macrophages and mesenchymal stem cells (MSCs) during the proinflammatory stage of bone repair. However, the exact role of M1 macrophages in MSC function and bone repair is unknown. This study aimed to define the role of M1 macrophages at bone injury sites via the function of 1,25-Dihydroxyvitamin D (1,25[OH] 2 D) in suppressing M1 but promoting M2 differentiation. We showed that 1,25(OH) 2 D suppressed M1 macrophage–mediated enhancement of MSC migration. Additionally, 1,25(OH) 2 D inhibited M1 macrophage secretion of osteogenic proteins (i.e., Oncostatin M, TNF-α, and IL-6). Importantly, the 1,25(OH) 2 D-mediated suppression of osteogenic function in M1 macrophages at the proinflammatory stage was associated with 1,25(OH) 2 D-mediated reduction of MSC abundance, compromised osteogenic potential of MSCs, and impairment of fracture repair. Furthermore, outside the proinflammatory stage, 1,25(OH) 2 D treatment did not suppress fracture repair. Accordingly, our data support 2 conclusions: (a) M1 macrophages are important for the recruitment and osteogenic priming of MSCs and, hence, are necessary for fracture repair, and (b) under vitamin D–sufficient conditions, 1,25(OH) 2 D treatment is unnecessary and can be detrimental if provided during the proinflammatory stage of fracture healing.